The mental health and wellbeing of our people is vitally important. It is a natural extension of our company’s purpose to discover new ways to improve and extend people’s lives. Our ambition at ...

V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...

Territory Business Executive Regular (Sales), Full time Universal Hierarchy Node Indien Gujarat Mai 30, 2025 ...

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the ...

Clinical Development Medical Director Regular, Full time Universal Hierarchy Node USA East Hanover Giu 01, 2025 Assoc. Expert - Technical Development Cell Therapy PD Regular, Full time Universal ...

Regulus filed a solicitation/recommendation statement on Schedule 14D-9 with the SEC, which includes, among other things, the recommendation of Regulus’s board of directors that Regulus’s stockholders ...

For the estimated 2.8 million people 1 living with multiple sclerosis (MS) worldwide, diagnosis is life-altering and can be overwhelming. The symptoms, including loss of vision, movement and sensation ...

Spoločnosť Novartis je hrdá na viacero ocenení za pokrokové objavy a prínos v oblasti výskumu a vývoja, vynikajúce pracovné prostredie a taktiež aktivity v oblasti spoločenskej zodpovednosti. Access ...

To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.

The company will make a total investment of $23B over the next five years, creating: Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities New ...